GAPDH and Alzheimer disease: Our network pharmacology analysis provides a valuable framework for hypothesis generation by identifying potential mechanisms of action and highlighting key AD-related targets like APP, GAPDH, CASP3, PTGS2, GSK3B, and PPARG, along with relevant modulated pathways.